• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.

作者信息

Brickman A S, Sherrard D J, Jowsey J, Singer F R, Baylink D J, Maloney N, Massry S G, Norman A W, Coburn J W

出版信息

Arch Intern Med. 1974 Nov;134(5):883-8. doi: 10.1001/archinte.134.5.883.

DOI:10.1001/archinte.134.5.883
PMID:4613310
Abstract
摘要

相似文献

1
1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.1,25-二羟胆钙化醇。对尿毒症性骨营养不良骨骼病变及血浆甲状旁腺激素水平的影响。
Arch Intern Med. 1974 Nov;134(5):883-8. doi: 10.1001/archinte.134.5.883.
2
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.1,25(OH)₂D₃在肾性骨营养不良管理中的应用现状
Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154.
3
Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
Adv Exp Med Biol. 1978;103:473-86. doi: 10.1007/978-1-4684-7758-0_48.
4
The clinical use of synthetic 1,25-dihydroxycholecalciferol.合成1,25 - 二羟胆钙化醇的临床应用。
Calcif Tissue Res. 1976 Aug;21 Suppl:236-41.
5
Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
Am J Med. 1974 Jul;57(1):28-33. doi: 10.1016/0002-9343(74)90764-5.
6
Long-term therapy of uremic osteodystrophy in adults with calcitriol.成人尿毒症性骨营养不良的骨化三醇长期治疗
Clin Nephrol. 1981 Aug;16(2):93-100.
7
Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
Ann Intern Med. 1981 Mar;94(3):404-5. doi: 10.7326/0003-4819-94-3-404.
8
The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.1α(OH)D3和1α,25(OH)2D3对肾性骨营养不良患者骨骼的影响。
Am J Med. 1978 Jan;64(1):101-7. doi: 10.1016/0002-9343(78)90184-5.
9
Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
J Urol Nephrol (Paris). 1974 Dec;80(12):984-5.
10
[Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
Rev Rhum Mal Osteoartic. 1978 Apr;45(4):241-8.

引用本文的文献

1
"Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemia.促红细胞生成素抵抗性贫血中的“理想”甲状旁腺激素
EJHaem. 2021 Nov 24;3(1):159-162. doi: 10.1002/jha2.316. eCollection 2022 Feb.
2
Parathyroid Hormone: A Uremic Toxin.甲状旁腺激素：一种尿毒症毒素。
Toxins (Basel). 2020 Mar 17;12(3):189. doi: 10.3390/toxins12030189.
3
Renal Osteodystrophy-Time for Common Nomenclature.肾性骨营养不良——采用通用术语的时候了。
Curr Osteoporos Rep. 2017 Jun;15(3):187-193. doi: 10.1007/s11914-017-0367-y.
4
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.西那卡塞长期治疗继发性甲状旁腺功能亢进透析患者前后的骨组织形态计量学研究
Kidney Int. 2015 Apr;87(4):846-56. doi: 10.1038/ki.2014.349. Epub 2014 Oct 22.
5
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.血清 24,25-二羟维生素 D 浓度是维生素 D 代谢的标志物，在慢性肾脏病中降低。
Kidney Int. 2012 Sep;82(6):693-700. doi: 10.1038/ki.2012.193. Epub 2012 May 30.
6
Serum calcium and phosphate concentrations and parathyroid morphology in rats treated with vitamin D metabolites.用维生素D代谢物治疗的大鼠的血清钙、磷浓度及甲状旁腺形态
Urol Res. 1980;8(3):181-7. doi: 10.1007/BF00256415.
7
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].儿童肾性骨营养不良。1,25 - 二羟胆钙化醇治疗（作者译）
Klin Wochenschr. 1980 May 16;58(10):511-9. doi: 10.1007/BF01477068.
8
Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.用1,25 - 二羟胆钙化醇治疗肾性骨营养不良。
Can Med Assoc J. 1981 Mar 1;124(5):577-83.
9
Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.接受维持性血液透析的无症状甲状旁腺功能亢进患者口服1,25-二羟基维生素D3与安慰剂的双盲试验。
Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1919-24. doi: 10.1136/bmj.282.6280.1919.
10
24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.维生素D缺乏的氮质血症大鼠体内的24,25(OH)2D3、骨形成与骨吸收
Calcif Tissue Int. 1984 Mar;36(2):206-13. doi: 10.1007/BF02405319.